Marshall Wace’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,155,402
Closed -$114M 2906
2024
Q4
$114M Buy
5,155,402
+2,410,420
+88% +$53.1M 0.14% 121
2024
Q3
$49.5M Sell
2,744,982
-1,427,611
-34% -$25.7M 0.06% 263
2024
Q2
$67.8M Sell
4,172,593
-42,623
-1% -$693K 0.09% 196
2024
Q1
$59.5M Buy
4,215,216
+2,152,814
+104% +$30.4M 0.09% 195
2023
Q4
$21.5M Sell
2,062,402
-318,572
-13% -$3.33M 0.04% 398
2023
Q3
$24.3M Buy
2,380,974
+1,182,072
+99% +$12.1M 0.05% 345
2023
Q2
$9.03M Buy
+1,198,902
New +$9.03M 0.02% 677
2023
Q1
Sell
-48,771
Closed -$445K 2586
2022
Q4
$445K Buy
48,771
+1,273
+3% +$11.6K ﹤0.01% 1854
2022
Q3
$383K Sell
47,498
-2,052,207
-98% -$16.5M ﹤0.01% 2132
2022
Q2
$15.8M Buy
+2,099,705
New +$15.8M 0.03% 529
2022
Q1
Sell
-1,049,916
Closed -$8.41M 3301
2021
Q4
$8.41M Buy
1,049,916
+1,030,470
+5,299% +$8.25M 0.02% 920
2021
Q3
$190K Buy
+19,446
New +$190K ﹤0.01% 2217
2019
Q3
Sell
-1,935,491
Closed -$17.9M 1877
2019
Q2
$17.9M Buy
+1,935,491
New +$17.9M 0.15% 149
2018
Q3
Sell
-25,484
Closed -$620K 1277
2018
Q2
$620K Buy
+25,484
New +$620K 0.01% 555
2016
Q4
Sell
-231,251
Closed -$10.6M 1114
2016
Q3
$10.6M Buy
+231,251
New +$10.6M 0.08% 270
2016
Q2
Sell
-210,159
Closed -$11.2M 1153
2016
Q1
$11.2M Sell
210,159
-922,492
-81% -$49.4M 0.11% 198
2015
Q4
$74.3M Buy
1,132,651
+1,080,061
+2,054% +$70.9M 0.7% 20
2015
Q3
$2.97M Sell
52,590
-79,709
-60% -$4.5M 0.04% 373
2015
Q2
$7.82M Buy
132,299
+102,182
+339% +$6.04M 0.1% 222
2015
Q1
$1.88M Sell
30,117
-68,463
-69% -$4.26M 0.02% 477
2014
Q4
$5.67M Sell
98,580
-282,318
-74% -$16.2M 0.07% 284
2014
Q3
$20.5M Sell
380,898
-59,516
-14% -$3.2M 0.3% 99
2014
Q2
$23.1M Buy
440,414
+73,343
+20% +$3.84M 0.34% 80
2014
Q1
$19.4M Buy
+367,071
New +$19.4M 0.35% 84